OnCore Clinical Trial Management System (CTMS) Minimum Standardized Requirements: School of Dentistry
|
|
- Leonard Jackson
- 7 years ago
- Views:
Transcription
1 OnCore Clinical Trial Management System (CTMS) Minimum Standardized Requirements: School of Dentistry OnCore CTMS Registration Requirements Main Tab Institution Tab Reviews Tab Status Tab Accrual Tab Version 2 12Feb2016 OnCore Version 14.0 This guide should be followed when entering and updating protocol information for research conducted within the School of Dentistry. OnCore Questions OnCore@iupui.edu Phone: OnCore Website
2 OnCore CTMS Registration Requirements for Research at Indiana University and IU Health This document provides the necessary information to successfully onboard to OnCore and integrate with other IU and IU Health systems used in clinical research. Definitions Clinical Study: A research study using human subjects to evaluate biomedical or health-related outcomes. Prospective: Data collection starts with the present condition of a population of individuals and follows them into the future. OnCore Protocol Types- definitions from ClinicalTrial.gov : 1. Observational: Studies in human beings in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study. This may include Patient Registries. 2. Interventional: Studies in human beings in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed. 3. Expanded Access (e.g. compassionate use): Records describing the procedure for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in a controlled clinical study. Expanded Access records are used to register all types of non-protocol access to experimental treatments, including protocol exception, single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track. See flow diagram on following page: -2-
3
4 PC Console > Main > Details
5 PC Console > Main > Details>Protocol Details *Protocol No. The main identifier for a protocol. This needs to be a unique identifier for each protocol entered in OnCore. NCT number *Library *Department *Organizational Unit *Title Short Title *Age Formatting for identifier: Acronym for Primary Management-Group-Sponsor-PI-Short Title of Study OH-GSK-HARA for sponsored study OH-IIR-ZERO-EINSTEIN1 for investigator initiated protocol National Clinical Trial number found on Format example: NCT Field will not be available until other required fields are entered for this page and saved by hitting the Submit button. A library in Oncore determines the reference codes, forms, notifications and signoffs for a protocol. All protocols with an Organizational Unit of School of Dentistry must use a Library of Dentistry. Identifies the department OR department and division associated with the Principal Investigator of record at the IRB. Associated Department and Division for each PI can be located in the Admin > Staff Console. OnCore Support: OnCore@iupui.edu Organizational units are used to organize protocols into logical structural divisions, which is useful for reporting purposes and to restrict access to protocols. The organizational units available for selection are determined by the organizational units in your staff record. For Dentistry and Oral Health studies, the Organization Unit will be School of Dentistry. This field should always be verified before moving forward as it may autopopulate with incorrect information. Title is the full length title as listed on the protocol. This should match the title used in the KCIRB application. Please limit to 600 characters, if possible, to be consistent with ClinicalTrials.Gov field length. Short Title is an abbreviated version of the protocol title (i.e. sometimes the acronym for the study). Enter the age of the locally acceptable age group. Age is used to indicate the age group of the subjects that are eligible for this protocol, as listed in the protocol eligibility checklist. Based on NIH and NCI Definitions, select from one of the following categories: Children: Pediatric protocols where subject eligibility is 21 years of age and younger. Adults: Adult protocols where subject eligibility is 18 years of age and older. Both: Any protocols where the above age definitions overlap. IIR can be used instead of sponsor for investigator initiated research. This naming convention should be used by ALL protocols. Use when applicable not all protocols will have a NCT number. If you are unable to locate the PI s name in the Admin > Staff Console, contact OnCore support to add to the directory This field may autopopulate once the Library field is entered based on the privileges you are assigned. Studies including children will trigger the Consent at Age of Majority field to display Yes and prompt reconsenting of subjects once they reach 18. *Investigator Initiated Protocol Investigator Authored Protocols are studies that are authored or coauthored by an Indiana University/IU Health/Eskanazi/VA investigator regardless of sponsor/funding (federal, cooperative, consortium, industry). -5-
6 PC Console > Main > Details>Protocol Details Summary Accrual Info. Only This field is marked as 'Yes' when only summary subject data will be collected for a protocol. This enables the collection of subject accrual data summaries on the Accrual tab in PC Console, and disables individual patient registration. This setting cannot be changed once subjects are accrued to the protocol. Refer to page 20 for accrual entry guidelines. All School of Dentistry trials qualify for Summary Accrual Info only unless study procedures are being conducted at an IUH facility. *Protocol Type *Investigational Drug *Investigational Device Interventional Study (or Clinical Trial) :A clinical study in which participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes. The assignments are determined by the study protocol. Participants may receive diagnostic, therapeutic, or other types of interventions. Observational Study: A clinical study in which participants identified as belonging to study groups are assessed for biomedical or health outcomes. Participants may receive diagnostic, therapeutic, or other types of interventions, but the investigator does not assign participants to specific interventions (as in an interventional study). Expanded Access: A process regulated by the Food and Drug Administration (FDA) that allows manufacturers to provide investigational new drugs to patients with serious diseases or conditions who cannot participate in a clinical trial. Investigational Drug field is answered as Yes if the protocol includes at least one investigational agent. An investigational agent is defined as having an IND number, regardless of the holder. Investigational Device field is answered as Yes if the protocol includes at least one investigational device. An investigational device is defined as having an IDE number, regardless of the holder. Protocol Type should match the Study Type listed on ClinicalTrials.gov. (If protocol is registered with ClinicalTrials.gov) -6-
7 PC Console > Main > Details>Accrual Information *Protocol Target Accrual Protocol Target Accrual is the total number of patients or participants needed for the entire study as stated in the protocol. This number displays in the top header of most screens within OnCore. This field is required for protocols that have set accrual goals. If the study is multi-site, this field represents the accrual goal for all sites. RC Accrual Goal (Lower) The RC Accrual Goal (Lower) is the minimum side of the range for the research center estimated total accrual. This might be the same as the RC Total Accrual Goal (Upper) listed below. The Low Accrual Report utilizes this field and can be used in an institutional metrics report to determine which protocols have met their accrual goals. The RC includes IU clinics and Oral Health as well as Methodist, University, Riley and Eskenazi hospitals. *RC Total Accrual Goal (Upper) *Accrual Duration (Months) RC (Research Center) Total Accrual Goal (Upper) is the maximum side of the range of the estimated total accrual for the institution (cannot exceed the IRB approved Accrual). Should be the number approved by the IRB for consented subjects Accrual Duration (Months) estimates the number of months the protocol may be accepting patients or participants to accrue. This number should match the accrual duration on the IRB application. This is informational-only field and does not drive any OnCore functionality. See protocol synopsis for estimate. PC Console > Main > Details>Completion Dates *Primary Completion Date The date that the final subject was examined or received an intervention for the purposes of final collection of data for the primary outcome, whether the clinical trial concluded according to the pre-specified protocol or was terminated. (Defined by ClinicalTrials.Gov). The RC includes IU clinics and Oral Health as well as Methodist, University, Riley and Eskenazi hospitals. This can be updated at the actual study close-out. -7-
8 PC Console > Main > Management -8-
9 PC Console > Main > Management>Management Details IRB No. The Institution Review Board (IRB) number used by the Indiana University Institutional Review Board to track the protocol. The number entered should match the syntax of the number in KC IRB - 10 characters consisting of all numeric characters. Copy, cut, and paste directly from KC IRB. If deferral is received form IU IRB to use a central IRB, enter the IU IRB deferral number. *ICRC Participation This will be no unless the study utilizes the adult and/or pediatric CTSI Clinical Research Center (CRC). If Yes, complete the 3 fields associated with ICRC participation: ICRC No., ICRC Approval Date, ICRC Category. Coding Scheme Internal Account No. Hospital Account No. The AE and SAE categorization that is being used for the study. If you are unsure of what to choose, MedDRA should be selected. Enter the IU funded internal account number. Enter the IUH vendor account billing number. Found on the IUH research grant form. If using another facility s account (ex. Eskenazi) this field can be used for both numbers This field is required for any protocol entering SAE data into OnCore or OnCore ecrfs. Not all studies will have this account no. Use as applicable Not all studies will have this account no. Use as applicable PC Console > Main > Management>Administrative Groups Management All studies will have a selected primary management group. The Group primary management group is determined by your individual department, division, or research group. If your area uses secondary management groups, select the secondary group/groups as appropriate for the study. Management Groups are used for reporting and access privileges. The Primary Management Group must be indicated by checking the associated box. Be sure to check the Primary Management Group even if there is only one Management Group listed. -9-
10 PC Console > Main > Staff PC Console > Main > Staff>Protocol Staff Role At a minimum: Principal Investigator: PI of record at the IRB. There will be only one principal investigator per study. Research Coordinator: non nurse coordinator Protocol Creator: This is automatically assigned to the initial creator of the protocol in OnCore (do not delete this role). Staff Name Other Commonly used staff: Co-Investigator: Other physicians acting/intervening with subjects. Research Nurse: RN/LPN coordinator Data Coordinator: Staff supporting OnCore entry (use if applicable in the research area) Study Site Contact: Primary coordinator for the study Select the staff member you want added to the protocol (this is a find-asyou-type field that pulls from all active staff records). A staff member may be listed multiple times with different roles on a single protocol. OnCore@iupui.edu If you cannot find a staff member, contact OnCore support and request the staff member to be added to the directory. -10-
11 PC Console > Main > Sponsor PC Console > Main > Sponsor>Sponsor Details Sponsor Details All sponsors associated with the protocol. Each study must have a principal sponsor indicated. This is done by checking the Principal Sponsor box next to the appropriate sponsor. The Primary sponsor is the primary organization that oversees the implementation of a study and is responsible for data analysis. If sponsor is not listed, contact OnCore Support to have added to the directory Always check the Principal Sponsor so it show up in the header. OnCore Support: OnCore@iupui.edu -11-
12 PC Console > Main > IND/IDE PC Console > Main > IND/IDE/Details *ID IND or IDE number assigned by the FDA. *Holder Type Select Industry if IND/IDE is held by a pharmaceutical company. Select Investigator if IND/IDE is held by IU/IUH Principal Investigator or other IU/IUH faculty. Select NIH if IND/IDE is held by the NIH. Select Organization if IND/IDE is held by an organization other than Industry, NCI or NIH. *Holder Name The holder of the IND/IDE. Often this is a PI name, study sponsor name or cooperative group name. -12-
13 PC Console > Main > ClinicalTrials.gov PC Console > Main > ClinicalTrials.gov PC Console > Main > ClinicalTrials.gov>Responsible Party Responsible Party This field is applicable for ClinicalTrials.gov studies only and refers to the Sponsor, Principal Investigator, or Sponsor-Investigator who is responsible for submitting information about a clinical study to ClinicalTrials.gov and updating that information This field should only be completed if applicable. Sponsor: the entity (e.g., corporation or agency) that initiates the study Principal Investigator: the individual who serves as the principal investigator and is designated as responsible party, consistent with the conditions described in the statute Sponsor-Investigator: the individual who both initiates and conducts the study -13-
14 PC Console > Institution PC Console > Institution PC Console > Institution>Participating Institutions Institution Represents the entity participating in a protocol. Indiana University (IU) must always be added to a new protocol. For system management reasons-indiana University(IU) currently includes University, Riley, Methodist, and Eskenazi hospitals as well as Oral Health and multiple clinic sites. Other IU Health hospitals are listed as separate institutions. If the institution you are searching for is not available, contact OnCore support staff for assistance. Additional research Institution and Study Sites listed here should correspond with sites listed in KCIRB. The Uses Research Center box should be checked for all research institutions using the IU IRB. Only enrolling institutions need to be added here. -14-
15 PC Console >Review >Update IRB Review -15-
16 PC Console > Reviews > Review Information Review Date The date of the IRB review was conducted. If this date is unknown, you may enter the IRB approval date. When using the Financials, this date can be used to trigger IRB invoiceables. Submit Date The date the submission is sent to the IRB. This date is located in KCIRB or other central IRB system. Review Reason The reason for the IRB submission. The following IRB review is required to be entered within OnCore at a minimum: Initial Review: Initial IRB submission Additional IRB reviews are optional. Review Type Action The type of IRB review will either be Full, Expedited, Exempt The IRB s decision regarding the submission reviewed. The following IRB Actions are common actions that will be used : Approved: Required in order for a protocol to be opened to accrual Additional Actions are available for tracking purposes. Action Date The date of the IRB s action. For new protocols that have been approved by the IRB, the Action Date = the protocol approval date. Expiration Date The date the current IRB approval expires. The expiration date of the review will automatically become the expiration date for any documents included in the details section of the review (e.g. Consent Documents). All Action dates are located in KCIRB or another IRB system. The expiration date is located in KCIRB or another central IRB system. Review No. The submission number for each review. Example: Enter NS for New Study,A001, A002, etc for amendments, R001, R002, etc. for continuing reviews. The review number should reflect the KCIRB review number or, if using an External IRB, follow the numbering system for the specific company- WIRB or CIRB. -16-
17 PC Console >Status >Protocol Status -17-
18 PC Console>Status> PC Console > Status>Protocol Status Status Statuses are assigned and unassigned in a predetermined order. Detailed definitions can be found below. OnCore statuses should be kept up to date so they accurately reflect the current status of the protocol. Status information will also be reflected in Cerner PowerTrials for qualifying trials. REQUIRED Status Types: Individual research groups may decide to utilize "Protocol Signoffs. See additional information in the IRB Initial Approval definitions. Open to Accrual Closed to Accrual Suspended On Hold Terminated IRB Study Closure Abandoned New: Status automatically assigned when a protocol is initially entered in OnCore. The current date is also assigned at this time, but may be edited. IRB Initial Approval: Status automatically populates into the Status tab when the IRB Approval is entered in the PC Console Reviews tab. Protocol Signoffs: After the 'IRB Initial Approval' status occurs, Protocol Signoffs (e.g. 'Central Admin Signoff', 'Account Signoff') may be required. These are determined by individual research groups and will not allow you to Open to Accrual until all signoffs are complete. Staff with appropriate access will be notified to complete these signoffs and will be the only staff members that can advance the protocol. On Hold: Trial has not yet opened to accrual and the PI or Sponsor has requested that all work on the trial stop until an issue, e.g. contract, funding, drug supply, etc. is resolved. Trial status may also be changed to On Hold if a protocol amendment requires IRB approval before a trial can open to accrual. A study can be placed on hold more than once during a trial s start-up period. Abandoned: Study has been withdrawn before it was IRB approved and no further action is expected. Open to Accrual: Status selected after the site has been opened to accrual/enrollment (all required reviews complete, sponsor authorization obtained, research group fully prepared to begin seeing patients). -18-
19 PC Console > Status>Protocol Status Suspended: Status selected after Open to Accrual to indicate that the protocol and subject accrual have been temporarily suspended. Once a trial has suspended, the user is given the option to undo suspend. The undo suspend option should only be used in cases that the trial was suspended by accident (i.e. clicked on the wrong button). Clicking undo suspend will erase the trial suspension from the status history. Closed to Accrual: Status selected when the protocol is no longer accruing/enrolling subjects. IRB Study Closure: Status selected to indicate that protocol ran its intended course (was not abandoned or terminated) and was closed with the IRB. This can also be used to indicate a study has expired and will not be reapproved. Terminated: Status selected to indicate that the protocol ended prior to completing the expected outcome and has been terminated with the IRB. It may also be used after the IRB study closure to indicate that no further action is required on the trial (i.e. financials reconciled). Date The date the status became active. This date may be retroactive, but future dates may not be entered. Initiator The initiator of the decision to activate the status listed. Required for the following statuses: On Hold Abandoned Suspended Closed to Accrual Terminated Reason The reason for activating the status listed. Required for the following statuses: On Hold Abandoned Suspended Closed to Accrual Terminated -19-
20 Summary Accrual Info. Only PC Console > Accrual -20-
21 This information displays only when the Summary Accrual Only field is marked as Yes for a protocol. It enables the collection of subject accrual data summaries on the Accrual Tab in the PC Console and disables individual subject registration. The setting cannot be changed once subjects are accrued to the protocol PC Console > Accrual>Add Protocol Accrual From Date to Through Date Date range for the accrual data being captured. Data should be captured by month (i.e. monthly - Jan 1 to Jan 31). This allows for flexible reporting. Start date should not be prior to the Open to Accrual Date. Thru Date should not exceed the Close to Accrual Date. Accrual Number of subjects accrued for the criteria defined (i.e. Age/Race/Sex/Ethnicity/Recruiter). To be consistent with IRB subject count authorization, it is recommended that a subject be counted as "accrued" once the subject has been consented. Institution Select the Institution that accrued the subject. This list should populate with a drop-down based on the Institutions entered under the PC Console > Institutions. Institution Type Identifies the Institution type (VA, Research Center, Affiliate, Consortium Member). This should populate based on the Institution selected PC Console > Annotation Annotations The annotations page is where protocol annotations are viewed and updated. Protocol Annotations are used to collect protocol data that is not accounted for by standard OnCore fields. Work with OnCore Support to develop specific annotations for your research group. -21-
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance
Clinical Trials Reporting Program (CTRP) and Clinicaltrials.gov (CT.gov) Helpful tips and guidance Objectives NCI s Clinical Trials Reporting Program (CTRP) Overview CTRP What is it? CTRP is an NCI mandated
More informationChildren s Research Management System (CRMS) Version 3.0. Children s Hospital Colorado Research Institute Training Guide April 2015
Children s Research Management System (CRMS) Version 3.0 Children s Hospital Colorado Research Institute Training Guide April 2015 Table of Contents Operational Needs Assessment (ONA) 3 Visit Schedules
More informationPre-Questions. Mastering Clinical Research July 29, 2015
Pre-Questions Mastering Clinical Research July 29, 2015 1. To be compliant with SOP 2.1 Obtaining Informed Consent for greater than minimal risk interventional clinical trial, which Licensed Professional
More informationThis policy applies to research administrators, investigators, research staff, Human Investigation Committee (HIC) members and HIC staff.
REVIEW BY AN EXTERNAL INSTITUTIONAL REVIEW BOARD 233 1 of 5 PURPOSE The purpose of this policy is to establish a procedure for requesting authorization for an approved, external (non-beaumont) institutional
More informationOnCore Clinical Research Management System Standard Operating Procedures
Purpose: This standard operating procedure (SOP) provide definitions for terms used in the OnCore clinical research management system at Georgia Regents University (GRU). 2.0 Scope: Applies to all site
More informationAttachment B HIPAA-P03 Instructions for Completing IU s Authorization for Research Purposes
Attachment B HIPAA-P03 Instructions for Completing IU s Authorization for Research Purposes The HIPAA Privacy Rule generally prohibits health care providers from using or releasing protected health information
More informationSTANDARD OPERATING PROCEDURE FORMAL COVERAGE ANALYSIS
PURPOSE Establish a consistent comprehensive coverage analysis process that is well defined and performed on every clinical trial. UCSF REQUIREMENT Effective 6/1/2013, a formal coverage analysis must be
More informationDetermining who the investigators are and who the principal investigator is:
Responsibilities of the IRBs of the Health System and University for Research Conducted by Investigators from a Combination of the Following Institutions: the Health System, University, and Medical School
More informationYale Cancer Center Data and Safety Monitoring Committee Charter
Yale Cancer Center Data and Safety Monitoring Committee Charter Purpose/Mission The purpose of the Yale Cancer Center (YCC) Data and Safety Monitoring Committee (DSMC) is to provide ongoing data and safety
More informationMedical Billing Human Research Studies Seminar Notes
Audits If a department learns that an external audit is going to be initiated, the Billing Compliance Department and Research Administration should be notified when the scope of the audit involves billing
More informationKuali Coeus Research Administration Project Business Process Design Document: IRB Future State KC-IRB 4: 45 CFR 46.118 Designation
Design Document: IRB Future State 1. Overview NOTE: The purpose of this document is to describe the future process at MSU. This is the defined procedure, AFTER the implementation of the Kuali Coeus (KC)
More informationCOMET Clinical Trials Consortium
COMET Clinical Trials Consortium User Manual www.comettrials.com CCTC Founder Christine Brezden-Masley, MD PhD FRCPC Medical Oncologist, St. Michael s Hospital Assistant Professor, University of Toronto
More information12.0 Investigator Responsibilities
v. 5.13.13 12.0 Investigator Responsibilities 12.1 Policy Investigators are ultimately responsible for the conduct of research. Research must be conducted according to the signed Investigator statement,
More informationJeri & Noboru Oishi Symposium
Jeri & Noboru Oishi Symposium Using the NCI CIRB SWOG Fall Group Meeting Jeanne Hyatt M. Adler, Regency RN, in Chicago MPH, CCRP October 7-10, 2015 CTEP/DCTD/NCI9, 2013 AND LaTisa Hernandez, PA, CCRC,
More informationQuality Monitoring Checklist
Quality Monitoring Checklist Instructions: For each task below, the Quality Monitor indicates in the appropriate column if the Monitor accomplished the task by using the following codes Yes No N/A = Monitor
More informationGuidance for Sponsors, Investigators, and Institutional Review Boards. Questions and Answers on Informed Consent Elements, 21 CFR 50.
Guidance for Sponsors, Investigators, and Institutional Review Boards Questions and Answers on Informed Consent Elements, 21 CFR 50.25(c) (Small Entity Compliance Guide) U.S. Department of Health and Human
More informationGuidance on IRB Continuing Review of Research
NOTE: THIS GUIDANCE SUPERSEDES OHRP S JANUARY 15, 2007 GUIDANCE ENTITILED GUIDANCE ON CONTINUING REVIEW. CLICK HERE FOR THE JANUARY 15, 2007 GUIDANCE. Office for Human Research Protections Department of
More informationINVESTIGATOR MANUAL. Table of Contents
Table of Contents HRP-910 001 10 Sep 2014 Page 1 of 7 What is the purpose of this manual?... 2 What is Human Research?... 2 What is the Human Research Protection Program?... 2 What training does my staff
More informationSingapore Clinical Trials Register. Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY
Singapore Clinical Trials Register Foo Yang Tong Director Clinical Trials Branch Health Products Regulation Group HEALTH SCIENCES AUTHORITY Clinical Trial Register Global Trend EMA: EU Clinical Trials
More informationComprehensive Study Documents List (Biomedical Studies)
Comprehensive Study Documents List (Biomedical Studies) Investigators conducting human subjects research must maintain study documents in adherence to federal and state regulations, USC policies, and good
More informationAURA Clinical Trial FP Guidelines
AURA Clinical Trial FP Guidelines Table of Contents Overview 2 What is a Clinical Trial? Guidelines Acronym/ Abbreviations/ Key Codes FP Workflow.. Step 1: PC-O create CT.. 3 Step 2: OCR/ URA-M advance
More information2. For all clinical trials, the coverage analysis will also be audited to ensure compliance with the Medicare National Coverage Determination.
COMPLIANCE PROGRAM POLICY: Clinical Research Billing Audit Policy Effective Date: August 1, 2014 Last Updated: Page 1 of 8 I. POLICY All UC Irvine Health departments engaged in clinical research may be
More informationVersion Date: 03/17/2008 Page 1 of 8
The Jackson Health System Clinical Trials Office requires a complete submission of all required documents for the study to be accepted and reviewed by the JHS Clinical Research Review Committee (CRRC):
More informationCLINICAL RESEARCH ROLES CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES
CLINICAL RESEARCH ROLESCLINICAL RESEARCH ROLES 1. Clinical Study Team Principal Investigator Co Principal Investigator (Co PI) Research Coordinator Study Monitor Data manage Sponsor Post Doctoral Scholar
More informationTaulia Supplier Portal User Guide
Taulia Supplier Portal User Guide Version 2.1 Taulia Inc. Taulia GmbH 201 Mission Street, Ste. 900 Gladbacher Strasse 74 San Francisco, CA 94105 Phone +1 (415) 376 8280 40219 Düsseldorf Germany Fax +1
More informationCenterWatch. volunteering. clinical trial. for a. www.centerwatch.com
volunteering for a clinical trial www.centerwatch.com :: about this pamphlet This pamphlet provides an overview of the clinical trials process and answers frequently asked questions that many potential
More informationPrincipal Investigator Responsibilities for Education and Social/Behavioral Researchers
Principal Investigator Responsibilities for Education and Social/Behavioral Researchers Introduction The purpose of this module is to provide a basic understanding of the responsibilities of the principal
More informationGuidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions
Guidance for Industry Information Program on Clinical Trials for Serious or Life-Threatening Diseases and Conditions U.S. Department of Health and Human Services Food and Drug Administration Center for
More informationLaurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute
Laurie Shaker-Irwin, Ph.D., M.S. Co-Leader, Regulatory Knowledge and Research Ethics UCLA Clinical and Translational Science Institute Understand the protocol completely Recognize institutional polices
More informationThe Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial
The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial Clinical Research Operations & Regulatory Support (CRORS) Ann Glasse, RN, BSN, MBA Director-CRORS Objectives
More informationEffective Date: October 2015
University of Maryland Greenebaum Cancer Center UMGCC Standard Operating Procedure Title: Data & Safety Monitoring Plan Effective Date: October 2015 Procedure No: DSM001 University of Maryland Greenebaum
More informationUniversity of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol
University of Hawai i Human Studies Program Guidelines for Developing a Clinical Research Protocol Following are guidelines for writing a clinical research protocol for submission to the University of
More informationTRAINING GUIDE. TRAVEL AND EXPENSE CARD US Bank Access OnLine
TRAINING GUIDE TRAVEL AND EXPENSE CARD US Bank Access OnLine Prepared by: Procurement Services October 2015 Table of Contents Introduction... 2 Logging on to Access Online... 2 Menus Available for Cardholders...
More informationInvestigator Handbook to Human Research Activities. South Shore Hospital
Investigator Handbook to Human Research Activities South Shore Hospital 1 INVESTIGATOR HANDBOOK CONTENTS WHO IS INVOLVED IN RESEARCH Principal Investigator... 6 Site PI 6 Co-investigators 6 Biostatistician
More informationStudy Protocol Template
Study Protocol Template (Chart Reviews) Instructions: This protocol template is a tool to facilitate the development of a study protocol specifically designed for the investigator initiated studies. It
More informationInformatics Resources for Clinical Research. Jim Cimino, Geoff Gordon, Matt Wyatt and James Willig UAB Informatics Institute April 6, 2016
Informatics Resources for Clinical Research Jim Cimino, Geoff Gordon, Matt Wyatt and James Willig UAB Informatics Institute April 6, 2016 Today s Take-Home Messages Overview of the clinical informatics
More informationCTMS Protocol Planning, Setup, and Maintenance
CTMS Protocol Planning, Setup, and Maintenance Updated: 09-Jul-2014 Updated: 09-Jul-2014 Page 2 of 22 Table of Contents Protocol Planning and Setup... 6 Protocol Set-Up Process... 6 Protocol Setup Requirements
More informationFACT SHEET (Available at http://prsinfo.clinicaltrials.gov/) Registration at ClinicalTrials.gov: As required by Public Law 110-85, Title VIII
10/27/09 NOTE: Section 2, Timing of Registration at ClinicalTrials.gov, was revised on 10/23/09. This document supersedes the Fact Sheet issued on 11/09/07. Note that the new text is highlighted below.
More informationHow To Write A Binder Tab
Tool Summary Sheet Tool: Extramural Essential Documents Binder/File Tabs Purpose: To provide an organizational framework and guidance for filing paper versions of essential study documents (or referencing
More informationInstructions of ClinicalTrials.gov Protocol Registration
Instructions of ClinicalTrials.gov Protocol Registration STEP I: Getting Started 1. Create an account: contact RU ClinicalTrials.gov Protocol Registration System (PRS) Administrator Rebecca Chen (973-972.1149
More informationInvestigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)
March 1, 2006 M E M O R A N D U M F O R R E C O R D TO: FROM: SUBJECT: Deans Department Chairs Principal Investigators Brian Herman, Ph.D. Vice President for Research Investigator responsibilities for
More informationClinical Trials and SPA Fall, 2014
Clinical Trials and SPA Fall, 2014 Laura Williams Frances Spalding Sponsored Projects Administration What to Expect Review of key clinical trial concepts A common clinical trial process How SPA fits in
More informationResearch Administration. Clinical Trial Administration Part I: Overview of Clinical Trial Management. (Presented November 12 th and 14 th 2013)
Research Administration Clinical Trial Administration Part I: Overview of Clinical Trial Management (Presented November 12 th and 14 th 2013) Objective Provide an overview of the clinical trials lifecycle
More informationOffice of Clinical Research (OCR)
Office of Clinical Research (OCR) Your Partner in the Clinical Research Process h3p://bsdocr.bsd.uchicago.edu Phone: 834-1238 Susan L. Cohn, MD Dean for Clinical Research Professor of Pediatrics OCR Created
More informationU.S. Food and Drug Administration
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA s website for reference purposes only. It was current when produced, but is no longer maintained
More informationSharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com
SAMPLE CRA CV Sharon H. Johnson, BS, MS 123 Main Street Capital City, VA 00000 Phone: 434-555-1234 Email: shjohnson@email.com Education: Masters of Science, Healthcare Administration, Capital City University,
More informationPrincipal Investigator and Sub Investigator Responsibilities
Principal Investigator and Sub Investigator Responsibilities I. Purpose To define the roles and responsibilities of Principal Investigators conducting research at GRU. II. Definition The term Principal
More informationHuman Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities
This Guidance Document is to ensure that investigators and research personnel recognize their responsibilities associated with the conduct of human subject research by outlining their responsibilities,
More informationClinical Trials: Questions and Answers
Clinical Trials: Questions and Answers Key Points Clinical trials are research studies that test how well new medical approaches work in people (see Question 1). Every clinical trial has a protocol, which
More information1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:
1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance
More informationSubject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure
703 1 of 11 POLICY The Beaumont Research Coordinating Center (BRCC) will provide advice to clinical trial investigators on protocol development, content and format. Upon request, the BRCC will review a
More informationClinical Investigator Inspections and FDA-483 Observations
Clinical Investigator Inspections and FDA-483 Observations Nancy A. Bellamy, Investigator Bioresearch Specialist/ BIMO Coordinator FDA Detroit District Office October 2, 2013 Objectives Background on FDA
More informationEMMA Application v. 4.9 User Manual
EMMA Application v. 4.9 User Manual Prepared by: HP/DMDC 1600 N. Beauregard Street Alexandria, VA 22311 Abstract This guide describes how to use the EMMA system, which allows users to provision for required
More informationDecember 13, 2011 Maureen Coyne
December 13, 2011 Maureen Coyne No industry relationships No financial conflicts of interests Recent experience weighted toward industrysponsored clinical trials Information based on my experiences IRB
More informationTEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
More informationAccounts Payable. Vendors and Vouchers
Accounts Payable Vendors and Vouchers 1 Agenda Searching for Vendors Entering Vouchers Budget Checking Submitting for Approval Viewing Workflow Viewing Voucher Status Approving Vouchers Denying (returning)
More informationInvestigational Drugs: Investigational Drugs and Biologics
: I. PURPOSE The purpose of this policy is to establish procedures for the proper control, storage, use and handling of investigational drugs and biologics to ensure that adequate safeguards are in place
More informationSuccessFactors Learning: Scheduling Management
SuccessFactors Learning: Scheduling Management Classroom Guide v 6.4 For SuccessFactors Learning v 6.4 Last Modified 08/30/2011 2011 SuccessFactors, Inc. All rights reserved. Execution is the Difference
More informationDHHS/NIH/OD/OIR/OHSRP 1/2/2015
DHHS/NIH/OD/OIR/OHSRP 1/2/2015 The audience for this course is Principal Investigators (PIs), investigators and Research Coordinators (RCs) serving on the study team of human clinical studies and trials.
More informationClinical Trials (Post Award and CRMS) Dorothy Damron, Oncology Research Manager and CRMS Lead Scott Streibich, Clinical Research Revenue Cycle
Clinical Trials (Post Award and CRMS) Dorothy Damron, Oncology Research Manager and CRMS Lead Scott Streibich, Clinical Research Revenue Cycle 1 Objectives Key CRMS Functionality for Financial RAPs Centralizing
More informationCore Training Outline
Core Training Outline Modules: 1) Study Design 2) PI Oversight 3) Financial Management 4) Study Operations 5) Recruitment & Retention 6) Informed Consent 7) Investigational Products 8) Subject Safety 9)
More informationClinical Trials Management System (CTMS) Overview
Clinical Trials Management System (CTMS) Overview 8.DEC.2011 Biomedical Informatics Core (BIC) Retreat Elizabeth Micalizzi, Director, Communications and Integrated Technology, Research Affairs and VCU
More informationGuidance for Industry
Guidance for Industry Expanded Access to Investigational Drugs for Treatment Use Qs & As DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationSEPTA eps FREQUENTLY ASKED QUESTIONS
SEPTA eps FREQUENTLY ASKED QUESTIONS Can more than one person from my company register for the SEPTA eps? No. The Vendor Registration Form will register you under your Company Name so all employees should
More informationROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices
Clinical and Translational Science Institute / CTSI at the University of California, San Francisco Welcome to Online Training for Clinical Research Coordinators ROLE OF THE RESEARCH COORDINATOR Study Start-up
More informationResearch Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor.
Mentor Online IRB System IRB s require lots of documentation and managing this process can get to be a burden for both investigators and the IRB committee and administrator. The Mentor IRB system is designed
More informationSection 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership
Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership PROJECT MANAGEMENT - SCOPE DEFINITION AND MANAGEMENT Understands the
More informationUser Guide. Module 4: Managing Your Account
User Guide Module 4: Managing Your Account Module 4 provides information on how to manage your COMPASS account. The guide contains the following information: How to set up your Test Center. How to add
More informationNova Southeastern University Institutional Review Board Policies and Procedures
Nova Southeastern University Institutional Review Board Policies and Procedures Monitoring of Approved Research, Approval Duration, and Continuing Review Effective 03/08/2007; Revised 10/14/2010; 8/29/2011;
More informationCoventryOne Agent Portal User Guide
CoventryOne Agent Portal User Guide CoventryOne is an Individual Product underwritten by PersonalCare Insurance of Illinois, Inc. Welcome to the CoventryOne Agent Portal bringing the convenience of the
More informationGovernment of Saskatchewan Executive Council. Oracle Sourcing isupplier User Guide
Executive Council Oracle Sourcing isupplier User Guide Contents 1 Introduction to Oracle Sourcing and isupplier...6 1.0 Oracle isupplier...6 1.1 Oracle Sourcing...6 2 Customer Support...8 2.0 Communications
More informationClinical Trials Budgeting and Billing
Clinical Trials Budgeting and Billing Presented by: Ellen N. Jamieson, MS, MBA Director, Grants Administration Alexandria Hui, BA Manager, Clinical Trial Financial Analyst Rules and Regulations Medicare
More informationEmployee Work Hours Change (Temporary Basis)
PeopleSoft HR ECR Automation Process Employee Work Hours Change (Temporary Basis) May 2012 Table of Contents Create an Hours Change Request... 3 Hours Change Only Request Page... 9 Hours Change with Earnings
More informationNova Southeastern University Institutional Review Board Policies and Procedures
Page 1 of 14 Purpose: To establish policy with respect to the emergency use of unapproved drugs and biologics. Definitions: 1. IRB approval means the determination of the IRB that the research has been
More informationClassifying Adverse Events From Clinical Trials
Classifying Adverse Events From Clinical Trials Bernard LaSalle, Richard Bradshaw University of Utah, Biomedical Informatics, Salt Lake City, UT USA bernie.lasalle@hsc.utah.edu Abstract The use of adverse
More informationCoverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical
Coverage Analysis: The Cornerstone of Clinical Research Billing Presented by: Mary L. Veazie, CPA, MBA, CHC, CHRC Executive Director, Clinical Research Finance The University of Texas MD Anderson Cancer
More informationFI to FI Transfer Frequently Asked Questions
FI to FI Transfer Frequently Asked Questions FI to FI allows you to transfer money between your accounts at Minnesota National Bank and accounts you have at other financial institutions. This new service
More informationConfigure Guest Access
Cisco ISE Guest Services, page 1 Guest and Sponsor Accounts, page 2 Guest Portals, page 19 Sponsor Portals, page 31 Monitor Guest and Sponsor Activity, page 36 Guest Access Deployment Scenarios, page 37
More informationInsight 3.5: Release Date March 28, 2014. Help Desk/ Service Center # (If Available) Description. Internal TFS #
Insight 3.5: Release Date March 28, 2014 Internal TFS # Admin Introduction of the Research Management Applications System Help Desk/ Service Center # (If Available) Description On March 28th the Partners
More informationVersion 6.5 Users Guide
Version 6.5 Users Guide INTRODUCTION 9 HOW TO USE THIS GUIDE 9 INSTALLATION PROCEEDURE 10 SYSTEM OVERVIEW 12 SYSTEM CONCEPTS AND TERMINOLOGY 12 Requests 12 Problems 13 Changes 13 System Access and Menu
More informationExpanded Access Programs. Richard Klein Office of Special Health issues Food and Drug Administration
Expanded Access Programs Richard Klein Office of Special Health issues Food and Drug Administration Expanded Access Programs (EAPs) What is expanded access? History Legislative background General principles
More informationCancer Clinical Trials: In-Depth Information
Cancer Clinical Trials: In-Depth Information The Drug Development and Approval Process 1. Early research and preclinical testing 2. IND application filed with FDA 3. Clinical trials (phases 1, 2, and 3)
More informationProposal Development Guide
Proposal Development Guide Contents The Proposal Tab... 3 Document Overview Panel... 3 Required Fields for Saving Document Panel... 3 Institutional Fields (Conditionally Required)... 9 Sponsor & Program
More informationSecurity, Audit, and e-signature Administrator Console v1.2.x
Security, Audit, and e-signature Administrator Console v1.2.x USER GUIDE SAE Admin Console for use with: QuantStudio Design and Analysis desktop Software Publication Number MAN0010410 Revision A.0 For
More informationLive Agent for Support Agents
Live Agent for Support Agents Salesforce, Spring 16 @salesforcedocs Last updated: February 18, 2016 Copyright 2000 2016 salesforce.com, inc. All rights reserved. Salesforce is a registered trademark of
More informationContents: Centers for Medicare/Medicaid (CMS) Clinical Trials Policy (CTP) Training. CMS CTP Background, Definitions and Requirements
Contents: CMS CTP Background, Definitions and Requirements Process Going Forward UW Medicine Process Reminders April 2009, Slide 1 Background: In 2000, Medicare issued a National Coverage Decision (NCD)
More informationINVESTIGATOR HANDBOOK
INVESTIGATOR HANDBOOK Liberty IRB, Inc. 1450 S. Woodland Blvd., Suite 300A Deland, Florida 32720 Phone (386) 279-4318 Fax: (386)868-4563 Website: www.libertyirb.com Business hours: Monday Friday, 8:00am
More informationThe Ontario Cancer Research Ethics Board Overview
The Ontario Cancer Research Ethics Board Overview Research Ethics Research ethics review is vital to the advancement of ethically sound research. Before individuals can be enrolled in a research study,
More informationCustomer admin guide. UC Management Centre
Customer admin guide UC Management Centre June 2013 Contents 1. Introduction 1.1 Logging into the UC Management Centre 1.2 Language Options 1.3 Navigating Around the UC Management Centre 4 4 5 5 2. Customers
More informationThe following list consists of a few tips and tricks to use when navigating eirb.
TIPS/TRICKS The following list consists of a few tips and tricks to use when navigating eirb. GENERAL Submitting applications Only the PI can submit applications. However, the Study Coordinator can submit
More informationData Management in Clinical Trials
Data Management in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 19, 2013 Diane St. Germain, RN, MS Nurse Consultant Division of Cancer Prevention National Cancer
More informationGuidance for IRBs, Clinical Investigators, and Sponsors. Considerations When Transferring Clinical Investigation Oversight to Another IRB
Guidance for IRBs, Clinical Investigators, and Sponsors Considerations When Transferring Clinical Investigation Oversight to Another IRB U.S. Department of Health and Human Services Food and Drug Administration
More informationThe Utilization Threshold Program
The Utilization Threshold Program In order to contain costs while continuing to provide medically necessary care and services, the Utilization Threshold (UT) program places limits on the number of services
More informationAAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE
1 AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE Instructions Test Article means any drug, biological product,
More informationLOGO. HBS Bi-Weekly Exempt Employee Training. Bi-Weekly Exempt Timesheets. Updated 01.27.11
LOGO Bi-Weekly Exempt s HBS Bi-Weekly Exempt Employee Training Updated 01.27.11 Welcome to HBS Training! Welcome to the HBS online training for UCSF Exempt Employees paid on a Bi-Weekly pay cycle. This
More informationEXPRESSPATH PROVIDER PORTAL USER GUIDE AUGUST 2013
EXPRESSPATH PROVIDER PORTAL USER GUIDE AUGUST 2013 2013-2020 Express Scripts, Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic
More informationProSoftMod Commission Report Documentation
ProSoftMod Commission Report Documentation The purpose of these modifications is to produce commission reports by salesman. The reports can be done by total sales or gross profit. The can also by produced
More informationFebruary 2006 Procedural
Guidance for Industry Reports on the Status of Postmarketing Study Commitments Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997 U.S. Department of Health and
More informationData Management & Case Report Form Development in Clinical Trials. Introduction to the Principles and Practice of Clinical Research.
Data Management & Case Report Form Development in Clinical Trials Introduction to the Principles and Practice of Clinical Research February 3, 2015 Marge Good, RN, MPH, OCN Nurse Consultant Division of
More informationRegulatory Binder Instructions 25 April 2016
Regulatory Binder Instructions 25 April 2016 Instructions This Regulatory Binder is available to help study sites achieve and maintain regulatory compliance and adhere to high standards of practice in
More information